TNNT2 and cardiomyopathy: In patient-derived iPSC cardiomyocytes bearing a DCM-associated mutation in TNNT2, it was shown that cTnT accumulates in the nucleus and may regulate epigenetic modifications that exacerbate the pathogenesis of cardiomyopathy [37].